insights_auto
Why is ORX down २.९९%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK ५.१९
arrow_downward
-२.९९%(-०.१६) 1D
अक्टोबर २२, १५:४१:४५ GMT+२ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK ५.००
High
SEK ५.४३
Low
SEK ४.९५
Mkt. cap
१८.२३ करोड
Avg. vol.
१.१५ लाख
Volume
१.३८ लाख
P/E ratio
०.२२
52-wk high
SEK ३८.७५
52-wk low
SEK ४.९५
EPS
SEK २३.६१
Shares outstanding
३.५१ करोड
No. of employees
६१
Open
SEK ५.००
High
SEK ५.४३
Low
SEK ४.९५
Mkt. cap
१८.२३ करोड
Avg. vol.
१.१५ लाख
Volume
१.३८ लाख
P/E ratio
०.२२
52-wk high
SEK ३८.७५
52-wk low
SEK ४.९५
EPS
SEK २३.६१
Shares outstanding
३.५१ करोड
No. of employees
६१
News stories
From web sources and news partners
Investing.com Canada
·
१ घण्टा पहिले
Orexo Q3 2026 slides: platform shift advances despite deepening losses By Investing.com
Investing.com Canada
·
१ घण्टा पहिले
Earnings call transcript: Orexo Q3 2026 loss deepens as shares fall 7.1%
www.marketscreener.com
·
३ घण्टा पहिले
Orexo AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
TradingView
·
९ घण्टा पहिले
Sweden's Orexo Q3 revenue falls sharply, net loss widens
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB